Position in REPL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,005,401
+$683,057 QoQ
Shares Held
131,425
+296.3% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026XTX Topco Ltd holds $287,762,779 across 374 Biotechnology names. REPL ranks #81 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
255,431 | $7,075,438 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,632 | $6,980,313 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
80,519 | $6,046,171 | |
| 4 | EXEL |
Exelixis, Inc.
|
134,413 | $5,764,973 | |
| 5 | NUVL |
Nuvalent, Inc.
|
53,354 | $5,466,117 | |
| 6 | AGIO |
Agios Pharmaceuticals, Inc.
|
160,880 | $5,442,570 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
93,609 | $5,287,972 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
59,502 | $5,174,888 |
All Filings in REPL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,005,401 | 131,425 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $322,344 | 33,163 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $583,356 | 62,794 | Shares | Defined | 2025-08-12 | |
| 2024-12-31 | $137,291 | 11,337 | Shares | Defined | 2025-02-13 | |
| 2024-06-30 | $130,545 | 14,505 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $144,404 | 17,675 | Shares | Defined | 2024-05-13 | |
| 2023-09-30 | $211,941 | 12,387 | Shares | Defined | 2023-11-13 | |
| 2023-03-31 | $433,676 | 24,557 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $212,241 | 7,803 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||